These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36973590)

  • 1. Coordinated modification in expression levels of HSPA1A/B, DGKH, and NOTCH2 in Parkinson's patients' blood and substantia nigra as a diagnostic sign: the transcriptomes' relationship.
    Asad Samani L; Ghaedi K; Majd A; Peymani M; Etemadifar M
    Neurol Sci; 2023 Aug; 44(8):2753-2761. PubMed ID: 36973590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
    Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S
    Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
    Porrini V; Pilotto A; Vezzoli M; Lanzillotta A; Gennari MM; Bonacina S; Alberici A; Turrone R; Bellucci A; Antonini A; Padovani A; Pizzi M
    Neurobiol Dis; 2023 May; 180():106067. PubMed ID: 36893901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Proteostasis System Components in Peripheral Blood Mononuclear Cells in Parkinson Disease: Focusing on the HSP70 and p62 Levels.
    Vavilova JD; Boyko AA; Troyanova NI; Ponomareva NV; Fokin VF; Fedotova EY; Streltsova MA; Kust SA; Grechikhina MV; Shustova OA; Azhikina TL; Kovalenko EI; Sapozhnikov AM
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
    Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
    Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.
    Bergsland N; Zivadinov R; Schweser F; Hagemeier J; Lichter D; Guttuso T
    Mov Disord; 2019 Jul; 34(7):1006-1013. PubMed ID: 31180615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
    Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
    Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
    Wang Y; Wang Z
    Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.
    Mariani E; Frabetti F; Tarozzi A; Pelleri MC; Pizzetti F; Casadei R
    PLoS One; 2016; 11(9):e0161567. PubMed ID: 27611585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of B cell-related genes in peripheral blood leukocytes of Parkinson's disease patients with and without GBA mutations.
    Kobo H; Bar-Shira A; Dahary D; Gan-Or Z; Mirelman A; Goldstein O; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2016 Feb; 117(2):179-85. PubMed ID: 26410072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
    Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
    Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
    He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
    Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
    Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ
    Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs.
    Yang JO; Kim WY; Jeong SY; Oh JH; Jho S; Bhak J; Kim NS
    BMC Genomics; 2009 Dec; 10 Suppl 3(Suppl 3):S32. PubMed ID: 19958497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of alphaB-crystallin expression in the substantia nigra of patients with Parkinson's disease.
    Liu Y; Zhou Q; Tang M; Fu N; Shao W; Zhang S; Yin Y; Zeng R; Wang X; Hu G; Zhou J
    Neurobiol Aging; 2015 Apr; 36(4):1686-1691. PubMed ID: 25683516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.